FDA Participants for Barth Syndrome Listening Session March 3, 2021
Bhatt, Rhea (CDER - OEP/ Health Science Administrator)
Childers, Alexis (CDER - OND / Senior Regulatory Health PR)
Choe, Anna (CDER - OND / Physician)
Doan, Jenny (CDER – OND / Program Coordinator)
Donohue, Kathleen (CDER – OND / Division Director)
Farrell, Sheila (CDER – OND / Physician)
Hon, Christine (Yuen-Yi) (CDER – OTS / Pharmacologist)
Jackler, Karen (CBER – OD / Program Manager Patient Engagement)
Jeng, Linda (CDER – OND / Lead Physician)
Kane, Bridget (CDER – OND / Sr. Regulatory Health Project Manager)
Karp, Jacqueline (CDER – OND / Lead Physician)
Kozeli, Devi (CDER – OND / Sr. Regulatory Health Project Manager))
Lee, Kerry Jo (CDER – OND / Supervisor)
Lucarelli, Pamela K (CDER – OND / Director)
Luquetti, Daniela (CDER – OND / Senior Staff Fellow)
Melton, Christopher (CDER – PASE / Health Communications Specialist)
Punnoose, Ann (CDER – OND / Physician)
Rowzee, Anne (CBER – OTAT / Associate Director for Policy)
Smpokou, Patroula (CDER) Deputy Division Director Division of Rare Disease and Medical Genetics (DRDMG)
Stockbridge, Norman (CDER) Director Division of Cardiology and Nephrology (DCN)
Suzuki, Mari (CDER – OND / Physician)
Vaillancourt, Julienne (CBER – OD / Program Coordinator)
Welsh, Cynthia (CDER – OND / Physician)
White, Michael G (CDER – OND / Supervisor)
Winiecki, Scott (CDER – OND / Supervisory Physician)
Yu, Chongwoo (CDER – OTS / Chemist)
Zaidi, Anita (CDER – OND / Lead Physician)
Zand, Dina (CDER – OND / Physician)